amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce]
RxNorm concept 2059189, branded drug (sbd). Prescribable name: ARIKAYCE 590 MG in 8.4 ML Inhalation Suspension.
- RxCUI
- 2059189
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2059189 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ARIKAYCE 590 MG per 8.4 ML Inhalation Suspension; Arikayce 70.3 MG/ML Inhalation Suspension
Related concepts
- amikacin liposomal 70.3 MG/ML (SCDC, consists of)
- amikacin liposomal 70.3 MG/ML [Arikayce] (SBDC, consists of)
- Inhalation Suspension (DF, has dose form)
- Arikayce (BN, has ingredient)
- amikacin liposomal 70.3 MG/ML Inhalation Suspension (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2059189 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2059189 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2059189. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.